Search Results 2021-2030 of 18350 for Topical

  1. Rituximab in the Treatment of Idiopathic Membranous Nephropathy - Mayo Clinic

    About this study. Membranous glomerulopathy (MN) is still the most common glomerular disease associated with nephrotic proteinuria (NS).

  2. Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers

    PHOENIX — A drug combination designed to enhance the immune system's ability to zero in and attack cancer cells has shown a pronounced therapeutic effect ...

  3. Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells - Mayo Clinic

    This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult subjects exposed to Gene-modified (GM) T cell ...

  4. A Study to Compare Administering Olaparib Concurrently With Radiotherapy vs. Radiotherapy Alone in Treating Patients With Inflammatory Breast Cancer - Mayo Clinic

    The purpose of this study is to evaluate how well radiation therapy with or without olaparib works in treating patients with inflammatory breast cancer.

  5. Efbemalenograstim alfa-vuxw (subcutaneous route) - Side effects & uses - Mayo Clinic

    Efbemalenograstim alfa-vuxw injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form ...

  6. Obiltoxaximab (intravenous route) - Side effects & uses - Mayo Clinic

    Obiltoxaximab injection is used together with antibiotics to treat inhalational anthrax. It is also used to prevent inhalational anthrax after a person is ...

  7. TRC-PAD Program: In-Clinic Trial-Ready Cohort

    The purpose of this study is to develop a large, well-characterized, biomarker-confirmed, trial-ready cohort to facilitate rapid enrollment into AD prevention ...

  8. A Study Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma - Mayo Clinic

    PARPs are proteins that help repair DNA mutations. PARP inhibitors, such as olaparib, can keep PARP from working, so tumor cells can't repair themselves, and ...

  9. A Study to Evaluate Chlorhexidine Wipes to Reduce Surgical Site Infection Risk in Spine Surgery Patients - Mayo Clinic

    The purpose of this study is to determine the optimal length of use in days of the chlorhexidine gluconate wipes compared to standard wound care in the post- ...

  10. Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma - Mayo Clinic

    The purpose of this study is to establish a recommended phase 3 dose (RP3D) and to evaluate the efficacy, PK, and safety of tazemetostat + doxorubicin vs ...